Source: Advanced Cell Technology, Inc.
Posted: April 3, 2008 11:19 AM EDT
Summary:
Advanced Cell Technology, Inc. reports it has developed a large-scale differentiation process that has generated panels of differentiating human progenitor cell lines from human embryonic stem cells (hESCs):
"Advanced Cell Technology, Inc. reported on a large-scale differentiation process that has generated panels of differentiating human progenitor cell lines from human embryonic stem cells (hESCs). The research will be published in the April issue of Regenerative Medicine. ...One of the hurdles has been a commercially viable means for the expansion of sufficient numbers of the cell types needed for tissue regeneration. With the publication of work entitled 'The ACTCellerate Initiative: large-scale combinatorial cloning of novel human embryonic stem cell derivatives,' ACT scientists have solved some of these problems. The paper describes a system that was established to isolate and clonally expand tissue specific precursors that heretofore could only be isolated from aborted human fetal tissue."
